Percutaneous aortic valve replacement: New hope for inoperable and high-risk patients

Journal of Invasive Cardiology

Volumn 19, Issue 11, 2007, Pages 478-483

  Routledge, Helen C ^a   Lefèvre, Thierry ^a   Morice, Marie Claude ^a   De Marco, Federico ^a   Salmi, Lynda ^a   Cormier, Bertrand ^a  

^a INSTITUT HOSPITALIER JACQUES CARTIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; CLINICAL TRIAL; COMORBIDITY; CRIBIER EDWARDS PROSTHETIC VALVE; DISEASE SEVERITY; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MALIGNANT NEOPLASTIC DISEASE; PNEUMONIA; PREVALENCE; PROGNOSIS; REVIEW; STROKE;

AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PREVALENCE; RISK FACTORS;

EID: 35948965219     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225.
2. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery? Eur Heart J 2005;26:2714-2720.
3. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al. To operate or not on elderly patients with aortic stenosis: The decision and it s consequences. Heart 1999;82:143-148.
4. Bouma BJ, van den Brink RB, Zwinderman K, et al. Which elderly patients with severe aortic stenosis benefit from surgical treatment? An aid to clinical decision making. J Heart Valve Dis 200;13:374-381.
5. Cribier A, Savin T, Saoudi N, et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: An alternative to valve replacement? Lancet 1986;1:63-67.
6. Kuntz RE, Tosteson AN, Berman AD, et al. Predictors of event-free survival after balloon aorticval vuloplasty. N Engl J Med 1991;325:17-23.
7. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1994;89:642-650.
8. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002;106:3006-3008.
9. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006;47:1214-1223.
10. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850.
11. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation 2006;114:591-596.
12. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding prosthesis in high-risk patients with aortic valve disease: The Siegberg first- in-man study. Circulation 2006;114:1616-1624.
13. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aort ic valve replacement for severe aortic stenosis in high-risk patients using the second and current third generation self-expanding CoreValve prosthesis. J Am Coll Cardiol 2007;50:69-76.